APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasmid DNA (pDNA)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Plasmid DNA (pDNA) Market Analysis and Forecast 2026-2032

27 December 2025209 pages

Choose your research edition.

Industry ResearchPlasmid DNA (pDNA) Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasmid DNA (pDNA) Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Plasmid DNA (pDNA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasmid DNA (pDNA) Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasmid DNA (pDNA) Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Plasmid DNA (pDNA) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Plasmid DNA (pDNA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Plasmid DNA (pDNA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Plasmid DNA (pDNA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Plasmid DNA (pDNA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Plasmid DNA (pDNA) include GenScript Biotech, Xpress Biologics, WuXi Advanced Therapies, Waisman Biomanufacturing, Takara Bio, Synbio Technologies, Recipharm, Patheon and GenScript ProBio, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Plasmid DNA (pDNA), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plasmid DNA (pDNA), also provides the revenue of main regions and countries. Of the upcoming market potential for Plasmid DNA (pDNA), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plasmid DNA (pDNA) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasmid DNA (pDNA) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Plasmid DNA (pDNA) revenue, projected growth trends, production technology, application and end-user industry.

Plasmid DNA (pDNA) Segment by Company

GenScript Biotech

Xpress Biologics

WuXi Advanced Therapies

Waisman Biomanufacturing

Takara Bio

Synbio Technologies

Recipharm

Patheon

GenScript ProBio

Eurogentec

Esco Aster

Creative Biolabs

Charles River Laboratories

Catalent Biologics

Biovian

Andelyn Biosciences

Aldevron

Akron Biotech

AGC Biologics

Plasmid DNA (pDNA) Segment by Type

Research Grade Plasmid DNA

Commercial Grade Plasmid DNA

Plasmid DNA (pDNA) Segment by Application

Cancers

Viral Infections

Inherited Disorders

Other

Plasmid DNA (pDNA) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA (pDNA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA (pDNA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA (pDNA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Plasmid DNA (pDNA) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Plasmid DNA (pDNA) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasmid DNA (pDNA) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plasmid DNA (pDNA) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Research Grade Plasmid DNA Major Player Table 3. Commercial Grade Plasmid DNA Major Player Table 4. Global Plasmid DNA (pDNA) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cancers Major Player Table 6. Viral Infections Major Player Table 7. Inherited Disorders Major Player Table 8. Other Major Player Table 9. Plasmid DNA (pDNA) Industry Trends Table 10. Plasmid DNA (pDNA) Industry Drivers Table 11. Plasmid DNA (pDNA) Industry Opportunities and Challenges Table 12. Plasmid DNA (pDNA) Industry Restraints Table 13. Global Plasmid DNA (pDNA) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Plasmid DNA (pDNA) Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Plasmid DNA (pDNA) Market Share by Region (2021-2026) Table 16. Global Plasmid DNA (pDNA) Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Plasmid DNA (pDNA) Market Share by Region (2027-2032) Table 18. Global Plasmid DNA (pDNA) Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Plasmid DNA (pDNA) Revenue Market Share by Players (2021-2026) Table 20. Global Plasmid DNA (pDNA) Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Plasmid DNA (pDNA) Key Players Headquarters & Area Served Table 22. Global Plasmid DNA (pDNA) Players, Product Type & Application Table 23. Global Plasmid DNA (pDNA) Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Plasmid DNA (pDNA) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Plasmid DNA (pDNA) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Plasmid DNA (pDNA) Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Plasmid DNA (pDNA) Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Plasmid DNA (pDNA) Revenue Market Share by Type (2021-2026) Table 30. Global Plasmid DNA (pDNA) Revenue Market Share by Type (2027-2032) Table 31. Global Plasmid DNA (pDNA) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Plasmid DNA (pDNA) Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Plasmid DNA (pDNA) Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Plasmid DNA (pDNA) Revenue Market Share by Application (2021-2026) Table 35. Global Plasmid DNA (pDNA) Revenue Market Share by Application (2027-2032) Table 36. GenScript Biotech Company Information Table 37. GenScript Biotech Business Overview Table 38. GenScript Biotech Plasmid DNA (pDNA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. GenScript Biotech Plasmid DNA (pDNA) Product Portfolio Table 40. GenScript Biotech Recent Development Table 41. Xpress Biologics Company Information Table 42. Xpress Biologics Business Overview Table 43. Xpress Biologics Plasmid DNA (pDNA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Xpress Biologics Plasmid DNA (pDNA) Product Portfolio Table 45. Xpress Biologics Recent Development Table 46. WuXi Advanced Therapies Company Information Table 47. WuXi Advanced Therapies Business Overview Table 48. WuXi Advanced Therapies Plasmid DNA (pDNA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. WuXi Advanced Therapies Plasmid DNA (pDNA) Product Portfolio Table 50. WuXi Advanced Therapies Recent Development Table 51. Waisman Biomanufacturing Company Information Table 52. Waisman Biomanufacturing Business Overview Table 53. Waisman Biomanufacturing Plasmid DNA (pDNA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Waisman Biomanufacturing Plasmid DNA (pDNA) Product Portfolio Table 55. Waisman Biomanufacturing Recent Development Table 56. Takara Bio Company Information Table 57. Takara Bio Business Overview Table 58. Takara Bio Plasmid DNA (pDNA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Takara Bio Plasmid DNA (pDNA) Product Portfolio Table 60. Takara Bio Recent Development Table 61. Synbio Technologies Company Information Table 62. Synbio Technologies Business Overview Table 63. Synbio Technologies Plasmid DNA (pDNA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Synbio Technologies Plasmid DNA (pDNA) Product Portfolio Table 65. Synbio Technologies Recent Development Table 66. Recipharm Company Information Table 67. Recipharm Business Overview Table 68. Recipharm Plasmid DNA (pDNA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Recipharm Plasmid DNA (pDNA) Product Portfolio Table 70. Recipharm Recent Development Table 71. Patheon Company Information Table 72. Patheon Business Overview Table 73. Patheon Plasmid DNA (pDNA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Patheon Plasmid DNA (pDNA) Product Portfolio Table 75. Patheon Recent Development Table 76. GenScript ProBio Company Information Table 77. GenScript ProBio Business Overview Table 78. GenScript ProBio Plasmid DNA (pDNA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. GenScript ProBio Plasmid DNA (pDNA) Product Portfolio Table 80. GenScript ProBio Recent Development Table 81. Eurogentec Company Information Table 82. Eurogentec Business Overview Table 83. Eurogentec Plasmid DNA (pDNA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Eurogentec Plasmid DNA (pDNA) Product Portfolio Table 85. Eurogentec Recent Development Table 86. Esco Aster Company Information Table 87. Esco Aster Business Overview Table 88. Esco Aster Plasmid DNA (pDNA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Esco Aster Plasmid DNA (pDNA) Product Portfolio Table 90. Esco Aster Recent Development Table 91. Creative Biolabs Company Information Table 92. Creative Biolabs Business Overview Table 93. Creative Biolabs Plasmid DNA (pDNA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Creative Biolabs Plasmid DNA (pDNA) Product Portfolio Table 95. Creative Biolabs Recent Development Table 96. Charles River Laboratories Company Information Table 97. Charles River Laboratories Business Overview Table 98. Charles River Laboratories Plasmid DNA (pDNA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Charles River Laboratories Plasmid DNA (pDNA) Product Portfolio Table 100. Charles River Laboratories Recent Development Table 101. Catalent Biologics Company Information Table 102. Catalent Biologics Business Overview Table 103. Catalent Biologics Plasmid DNA (pDNA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Catalent Biologics Plasmid DNA (pDNA) Product Portfolio Table 105. Catalent Biologics Recent Development Table 106. Biovian Company Information Table 107. Biovian Business Overview Table 108. Biovian Plasmid DNA (pDNA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Biovian Plasmid DNA (pDNA) Product Portfolio Table 110. Biovian Recent Development Table 111. Andelyn Biosciences Company Information Table 112. Andelyn Biosciences Business Overview Table 113. Andelyn Biosciences Plasmid DNA (pDNA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Andelyn Biosciences Plasmid DNA (pDNA) Product Portfolio Table 115. Andelyn Biosciences Recent Development Table 116. Aldevron Company Information Table 117. Aldevron Business Overview Table 118. Aldevron Plasmid DNA (pDNA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Aldevron Plasmid DNA (pDNA) Product Portfolio Table 120. Aldevron Recent Development Table 121. Akron Biotech Company Information Table 122. Akron Biotech Business Overview Table 123. Akron Biotech Plasmid DNA (pDNA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Akron Biotech Plasmid DNA (pDNA) Product Portfolio Table 125. Akron Biotech Recent Development Table 126. AGC Biologics Company Information Table 127. AGC Biologics Business Overview Table 128. AGC Biologics Plasmid DNA (pDNA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. AGC Biologics Plasmid DNA (pDNA) Product Portfolio Table 130. AGC Biologics Recent Development Table 131. North America Plasmid DNA (pDNA) Revenue by Type (2021-2026) & (US$ Million) Table 132. North America Plasmid DNA (pDNA) Revenue by Type (2027-2032) & (US$ Million) Table 133. North America Plasmid DNA (pDNA) Revenue by Application (2021-2026) & (US$ Million) Table 134. North America Plasmid DNA (pDNA) Revenue by Application (2027-2032) & (US$ Million) Table 135. North America Plasmid DNA (pDNA) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Plasmid DNA (pDNA) Revenue by Country (2021-2026) & (US$ Million) Table 137. North America Plasmid DNA (pDNA) Revenue by Country (US$ Million) & (2027-2032) Table 138. Europe Plasmid DNA (pDNA) Revenue by Type (2021-2026) & (US$ Million) Table 139. Europe Plasmid DNA (pDNA) Revenue by Type (2027-2032) & (US$ Million) Table 140. Europe Plasmid DNA (pDNA) Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Plasmid DNA (pDNA) Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Plasmid DNA (pDNA) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Plasmid DNA (pDNA) Revenue by Country (2021-2026) & (US$ Million) Table 144. Europe Plasmid DNA (pDNA) Revenue by Country (US$ Million) & (2027-2032) Table 145. China Plasmid DNA (pDNA) Revenue by Type (2021-2026) & (US$ Million) Table 146. China Plasmid DNA (pDNA) Revenue by Type (2027-2032) & (US$ Million) Table 147. China Plasmid DNA (pDNA) Revenue by Application (2021-2026) & (US$ Million) Table 148. China Plasmid DNA (pDNA) Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Plasmid DNA (pDNA) Revenue by Type (2021-2026) & (US$ Million) Table 150. Asia Plasmid DNA (pDNA) Revenue by Type (2027-2032) & (US$ Million) Table 151. Asia Plasmid DNA (pDNA) Revenue by Application (2021-2026) & (US$ Million) Table 152. Asia Plasmid DNA (pDNA) Revenue by Application (2027-2032) & (US$ Million) Table 153. Asia Plasmid DNA (pDNA) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Plasmid DNA (pDNA) Revenue by Region (US$ Million) & (2021-2026) Table 155. Asia Plasmid DNA (pDNA) Revenue by Region (US$ Million) & (2027-2032) Table 156. SAMEA Plasmid DNA (pDNA) Revenue by Type (2021-2026) & (US$ Million) Table 157. SAMEA Plasmid DNA (pDNA) Revenue by Type (2027-2032) & (US$ Million) Table 158. SAMEA Plasmid DNA (pDNA) Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Plasmid DNA (pDNA) Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Plasmid DNA (pDNA) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. SAMEA Plasmid DNA (pDNA) Revenue by Country (2021-2026) & (US$ Million) Table 162. SAMEA Plasmid DNA (pDNA) Revenue by Country (US$ Million) & (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Plasmid DNA (pDNA) Image Figure 2. Global Plasmid DNA (pDNA) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasmid DNA (pDNA) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Research Grade Plasmid DNA Image Figure 5. Commercial Grade Plasmid DNA Image Figure 6. Global Plasmid DNA (pDNA) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Plasmid DNA (pDNA) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cancers Image Figure 9. Viral Infections Image Figure 10. Inherited Disorders Image Figure 11. Other Image Figure 12. Global Plasmid DNA (pDNA) Market Size (US$ Million) & (2021-2032) Figure 13. Global Plasmid DNA (pDNA) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Plasmid DNA (pDNA) Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Plasmid DNA (pDNA) Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Plasmid DNA (pDNA) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Plasmid DNA (pDNA) Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Plasmid DNA (pDNA) Revenue Market Share by Type (2021-2032) Figure 20. Global Plasmid DNA (pDNA) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Plasmid DNA (pDNA) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Plasmid DNA (pDNA) Revenue Market Share by Application (2021-2032) Figure 23. North America Plasmid DNA (pDNA) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Plasmid DNA (pDNA) Revenue Share by Type (2021-2032) Figure 25. North America Plasmid DNA (pDNA) Revenue Share by Application (2021-2032) Figure 26. North America Plasmid DNA (pDNA) Revenue Share by Country (2021-2032) Figure 27. United States Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Plasmid DNA (pDNA) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Plasmid DNA (pDNA) Revenue Share by Type (2021-2032) Figure 32. Europe Plasmid DNA (pDNA) Revenue Share by Application (2021-2032) Figure 33. Europe Plasmid DNA (pDNA) Revenue Share by Country (2021-2032) Figure 34. Germany Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Plasmid DNA (pDNA) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Plasmid DNA (pDNA) Revenue Share by Type (2021-2032) Figure 44. China Plasmid DNA (pDNA) Revenue Share by Application (2021-2032) Figure 45. Asia Plasmid DNA (pDNA) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Plasmid DNA (pDNA) Revenue Share by Type (2021-2032) Figure 47. Asia Plasmid DNA (pDNA) Revenue Share by Application (2021-2032) Figure 48. Asia Plasmid DNA (pDNA) Revenue Share by Region (2021-2032) Figure 49. Japan Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Plasmid DNA (pDNA) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Plasmid DNA (pDNA) Revenue Share by Type (2021-2032) Figure 57. SAMEA Plasmid DNA (pDNA) Revenue Share by Application (2021-2032) Figure 58. SAMEA Plasmid DNA (pDNA) Revenue Share by Country (2021-2032) Figure 59. Brazil Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Plasmid DNA (pDNA) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Research Grade Plasmid DNA
  • Commercial Grade Plasmid DNA
Applications
  • Cancers
  • Viral Infections
  • Inherited Disorders
  • Other
Companies covered
  • GenScript Biotech
  • Xpress Biologics
  • WuXi Advanced Therapies
  • Waisman Biomanufacturing
  • Takara Bio
  • Synbio Technologies
  • Recipharm
  • Patheon
  • GenScript ProBio
  • Eurogentec
  • Esco Aster
  • Creative Biolabs
  • Charles River Laboratories
  • Catalent Biologics
  • Biovian
  • Andelyn Biosciences
  • Aldevron
  • Akron Biotech
  • AGC Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plasmid DNA (pDNA) Market by Type
  3. 1.2.1 Global Plasmid DNA (pDNA) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Research Grade Plasmid DNA
  5. 1.2.3 Commercial Grade Plasmid DNA
  6. 1.3 Plasmid DNA (pDNA) Market by Application
  7. 1.3.1 Global Plasmid DNA (pDNA) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cancers
  9. 1.3.3 Viral Infections
  10. 1.3.4 Inherited Disorders
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Plasmid DNA (pDNA) Market Dynamics
  1. 2.1 Plasmid DNA (pDNA) Industry Trends
  2. 2.2 Plasmid DNA (pDNA) Industry Drivers
  3. 2.3 Plasmid DNA (pDNA) Industry Opportunities and Challenges
  4. 2.4 Plasmid DNA (pDNA) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Plasmid DNA (pDNA) Market Perspective (2021-2032)
  2. 3.2 Global Plasmid DNA (pDNA) Growth Trends by Region
  3. 3.2.1 Global Plasmid DNA (pDNA) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plasmid DNA (pDNA) Market Size by Region (2021-2026)
  5. 3.2.3 Global Plasmid DNA (pDNA) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Plasmid DNA (pDNA) Revenue by Players
  2. 4.1.1 Global Plasmid DNA (pDNA) Revenue by Players (2021-2026)
  3. 4.1.2 Global Plasmid DNA (pDNA) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Plasmid DNA (pDNA) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plasmid DNA (pDNA) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Plasmid DNA (pDNA) Key Players Headquarters & Area Served
  7. 4.4 Global Plasmid DNA (pDNA) Players, Product Type & Application
  8. 4.5 Global Plasmid DNA (pDNA) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Plasmid DNA (pDNA) Market CR5 and HHI
  11. 4.6.3 2025 Plasmid DNA (pDNA) Tier 1, Tier 2, and Tier 3
5 Plasmid DNA (pDNA) Market Size by Type
  1. 5.1 Global Plasmid DNA (pDNA) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Plasmid DNA (pDNA) Revenue by Type (2021-2032)
  3. 5.3 Global Plasmid DNA (pDNA) Revenue Market Share by Type (2021-2032)
6 Plasmid DNA (pDNA) Market Size by Application
  1. 6.1 Global Plasmid DNA (pDNA) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Plasmid DNA (pDNA) Revenue by Application (2021-2032)
  3. 6.3 Global Plasmid DNA (pDNA) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GenScript Biotech
  2. 7.1.1 GenScript Biotech Company Information
  3. 7.1.2 GenScript Biotech Business Overview
  4. 7.1.3 GenScript Biotech Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GenScript Biotech Plasmid DNA (pDNA) Product Portfolio
  6. 7.1.5 GenScript Biotech Recent Developments
  7. 7.2 Xpress Biologics
  8. 7.2.1 Xpress Biologics Company Information
  9. 7.2.2 Xpress Biologics Business Overview
  10. 7.2.3 Xpress Biologics Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Xpress Biologics Plasmid DNA (pDNA) Product Portfolio
  12. 7.2.5 Xpress Biologics Recent Developments
  13. 7.3 WuXi Advanced Therapies
  14. 7.3.1 WuXi Advanced Therapies Company Information
  15. 7.3.2 WuXi Advanced Therapies Business Overview
  16. 7.3.3 WuXi Advanced Therapies Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 WuXi Advanced Therapies Plasmid DNA (pDNA) Product Portfolio
  18. 7.3.5 WuXi Advanced Therapies Recent Developments
  19. 7.4 Waisman Biomanufacturing
  20. 7.4.1 Waisman Biomanufacturing Company Information
  21. 7.4.2 Waisman Biomanufacturing Business Overview
  22. 7.4.3 Waisman Biomanufacturing Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Waisman Biomanufacturing Plasmid DNA (pDNA) Product Portfolio
  24. 7.4.5 Waisman Biomanufacturing Recent Developments
  25. 7.5 Takara Bio
  26. 7.5.1 Takara Bio Company Information
  27. 7.5.2 Takara Bio Business Overview
  28. 7.5.3 Takara Bio Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Takara Bio Plasmid DNA (pDNA) Product Portfolio
  30. 7.5.5 Takara Bio Recent Developments
  31. 7.6 Synbio Technologies
  32. 7.6.1 Synbio Technologies Company Information
  33. 7.6.2 Synbio Technologies Business Overview
  34. 7.6.3 Synbio Technologies Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Synbio Technologies Plasmid DNA (pDNA) Product Portfolio
  36. 7.6.5 Synbio Technologies Recent Developments
  37. 7.7 Recipharm
  38. 7.7.1 Recipharm Company Information
  39. 7.7.2 Recipharm Business Overview
  40. 7.7.3 Recipharm Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Recipharm Plasmid DNA (pDNA) Product Portfolio
  42. 7.7.5 Recipharm Recent Developments
  43. 7.8 Patheon
  44. 7.8.1 Patheon Company Information
  45. 7.8.2 Patheon Business Overview
  46. 7.8.3 Patheon Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Patheon Plasmid DNA (pDNA) Product Portfolio
  48. 7.8.5 Patheon Recent Developments
  49. 7.9 GenScript ProBio
  50. 7.9.1 GenScript ProBio Company Information
  51. 7.9.2 GenScript ProBio Business Overview
  52. 7.9.3 GenScript ProBio Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 GenScript ProBio Plasmid DNA (pDNA) Product Portfolio
  54. 7.9.5 GenScript ProBio Recent Developments
  55. 7.10 Eurogentec
  56. 7.10.1 Eurogentec Company Information
  57. 7.10.2 Eurogentec Business Overview
  58. 7.10.3 Eurogentec Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Eurogentec Plasmid DNA (pDNA) Product Portfolio
  60. 7.10.5 Eurogentec Recent Developments
  61. 7.11 Esco Aster
  62. 7.11.1 Esco Aster Company Information
  63. 7.11.2 Esco Aster Business Overview
  64. 7.11.3 Esco Aster Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Esco Aster Plasmid DNA (pDNA) Product Portfolio
  66. 7.11.5 Esco Aster Recent Developments
  67. 7.12 Creative Biolabs
  68. 7.12.1 Creative Biolabs Company Information
  69. 7.12.2 Creative Biolabs Business Overview
  70. 7.12.3 Creative Biolabs Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Creative Biolabs Plasmid DNA (pDNA) Product Portfolio
  72. 7.12.5 Creative Biolabs Recent Developments
  73. 7.13 Charles River Laboratories
  74. 7.13.1 Charles River Laboratories Company Information
  75. 7.13.2 Charles River Laboratories Business Overview
  76. 7.13.3 Charles River Laboratories Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Charles River Laboratories Plasmid DNA (pDNA) Product Portfolio
  78. 7.13.5 Charles River Laboratories Recent Developments
  79. 7.14 Catalent Biologics
  80. 7.14.1 Catalent Biologics Company Information
  81. 7.14.2 Catalent Biologics Business Overview
  82. 7.14.3 Catalent Biologics Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Catalent Biologics Plasmid DNA (pDNA) Product Portfolio
  84. 7.14.5 Catalent Biologics Recent Developments
  85. 7.15 Biovian
  86. 7.15.1 Biovian Company Information
  87. 7.15.2 Biovian Business Overview
  88. 7.15.3 Biovian Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Biovian Plasmid DNA (pDNA) Product Portfolio
  90. 7.15.5 Biovian Recent Developments
  91. 7.16 Andelyn Biosciences
  92. 7.16.1 Andelyn Biosciences Company Information
  93. 7.16.2 Andelyn Biosciences Business Overview
  94. 7.16.3 Andelyn Biosciences Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Andelyn Biosciences Plasmid DNA (pDNA) Product Portfolio
  96. 7.16.5 Andelyn Biosciences Recent Developments
  97. 7.17 Aldevron
  98. 7.17.1 Aldevron Company Information
  99. 7.17.2 Aldevron Business Overview
  100. 7.17.3 Aldevron Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Aldevron Plasmid DNA (pDNA) Product Portfolio
  102. 7.17.5 Aldevron Recent Developments
  103. 7.18 Akron Biotech
  104. 7.18.1 Akron Biotech Company Information
  105. 7.18.2 Akron Biotech Business Overview
  106. 7.18.3 Akron Biotech Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Akron Biotech Plasmid DNA (pDNA) Product Portfolio
  108. 7.18.5 Akron Biotech Recent Developments
  109. 7.19 AGC Biologics
  110. 7.19.1 AGC Biologics Company Information
  111. 7.19.2 AGC Biologics Business Overview
  112. 7.19.3 AGC Biologics Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  113. 7.19.4 AGC Biologics Plasmid DNA (pDNA) Product Portfolio
  114. 7.19.5 AGC Biologics Recent Developments
8 North America
  1. 8.1 North America Plasmid DNA (pDNA) Revenue (2021-2032)
  2. 8.2 North America Plasmid DNA (pDNA) Revenue by Type (2021-2032)
  3. 8.2.1 North America Plasmid DNA (pDNA) Revenue by Type (2021-2026)
  4. 8.2.2 North America Plasmid DNA (pDNA) Revenue by Type (2027-2032)
  5. 8.3 North America Plasmid DNA (pDNA) Revenue Share by Type (2021-2032)
  6. 8.4 North America Plasmid DNA (pDNA) Revenue by Application (2021-2032)
  7. 8.4.1 North America Plasmid DNA (pDNA) Revenue by Application (2021-2026)
  8. 8.4.2 North America Plasmid DNA (pDNA) Revenue by Application (2027-2032)
  9. 8.5 North America Plasmid DNA (pDNA) Revenue Share by Application (2021-2032)
  10. 8.6 North America Plasmid DNA (pDNA) Revenue by Country
  11. 8.6.1 North America Plasmid DNA (pDNA) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Plasmid DNA (pDNA) Revenue by Country (2021-2026)
  13. 8.6.3 North America Plasmid DNA (pDNA) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Plasmid DNA (pDNA) Revenue (2021-2032)
  2. 9.2 Europe Plasmid DNA (pDNA) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Plasmid DNA (pDNA) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Plasmid DNA (pDNA) Revenue by Type (2027-2032)
  5. 9.3 Europe Plasmid DNA (pDNA) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Plasmid DNA (pDNA) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Plasmid DNA (pDNA) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Plasmid DNA (pDNA) Revenue by Application (2027-2032)
  9. 9.5 Europe Plasmid DNA (pDNA) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Plasmid DNA (pDNA) Revenue by Country
  11. 9.6.1 Europe Plasmid DNA (pDNA) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Plasmid DNA (pDNA) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Plasmid DNA (pDNA) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Plasmid DNA (pDNA) Revenue (2021-2032)
  2. 10.2 China Plasmid DNA (pDNA) Revenue by Type (2021-2032)
  3. 10.2.1 China Plasmid DNA (pDNA) Revenue by Type (2021-2026)
  4. 10.2.2 China Plasmid DNA (pDNA) Revenue by Type (2027-2032)
  5. 10.3 China Plasmid DNA (pDNA) Revenue Share by Type (2021-2032)
  6. 10.4 China Plasmid DNA (pDNA) Revenue by Application (2021-2032)
  7. 10.4.1 China Plasmid DNA (pDNA) Revenue by Application (2021-2026)
  8. 10.4.2 China Plasmid DNA (pDNA) Revenue by Application (2027-2032)
  9. 10.5 China Plasmid DNA (pDNA) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plasmid DNA (pDNA) Revenue (2021-2032)
  2. 11.2 Asia Plasmid DNA (pDNA) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Plasmid DNA (pDNA) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Plasmid DNA (pDNA) Revenue by Type (2027-2032)
  5. 11.3 Asia Plasmid DNA (pDNA) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Plasmid DNA (pDNA) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Plasmid DNA (pDNA) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Plasmid DNA (pDNA) Revenue by Application (2027-2032)
  9. 11.5 Asia Plasmid DNA (pDNA) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Plasmid DNA (pDNA) Revenue by Country
  11. 11.6.1 Asia Plasmid DNA (pDNA) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Plasmid DNA (pDNA) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Plasmid DNA (pDNA) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plasmid DNA (pDNA) Revenue (2021-2032)
  2. 12.2 SAMEA Plasmid DNA (pDNA) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Plasmid DNA (pDNA) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Plasmid DNA (pDNA) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Plasmid DNA (pDNA) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Plasmid DNA (pDNA) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Plasmid DNA (pDNA) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Plasmid DNA (pDNA) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Plasmid DNA (pDNA) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Plasmid DNA (pDNA) Revenue by Country
  11. 12.6.1 SAMEA Plasmid DNA (pDNA) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Plasmid DNA (pDNA) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Plasmid DNA (pDNA) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst